Related Experiment Video
Updated: Oct 19, 2025
14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.3K
Uniformity in bioprosthetic mitral valve sizing-When will we get there?
Sven Z C P Tan1, Mohamad Bashir2, Idhrees Mohammed2
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.
Journal of Cardiac Surgery
|September 24, 2021
Summary
This study compared three bioprosthetic mitral valves in pigs. Researchers found significant differences in valve sizing and biomechanical performance, highlighting the need for standardization in manufacturing and selection.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Medical Device Technology
Background:
- Surgical valve repair has evolved significantly since the 1950s, with advancements in bioprosthetic valves and percutaneous techniques.
- Despite progress, a lack of direct, independent comparisons exists for bioprosthetic mitral valves.
- Heterogeneity in device sizing and selection criteria is a notable issue in current practice.
Purpose of the Study:
- To conduct a head-to-head evaluation of technical success and biomechanical outcomes for three distinct bioprosthetic mitral valves.
- To assess these valves under standardized hemodynamic and anatomical conditions within a porcine model.
- To identify and clarify the heterogeneity in sizing and biomechanical properties among different bioprosthetic mitral valve devices.
Main Methods:
- Utilized a robust experimental technique in a porcine model.
- Standardized hemodynamic and anatomical conditions were maintained throughout the study.
- Compared three specific bioprosthetic mitral valves: Epic (Abbott), Mosaic (Medtronic), and Mitris Resilia (Edwards Lifesciences).
Main Results:
- Demonstrated clear heterogeneity in sizing across the evaluated bioprosthetic mitral valves.
- Revealed significant variations in biomechanical properties between the different valve devices.
- The study provided a direct, independent comparison of device performance.
Conclusions:
- Bioprosthetic mitral valve devices exhibit marked heterogeneity in sizing and biomechanical characteristics.
- There is a critical need for a more uniform approach to the manufacturing and sizing of bioprosthetic valves.
- Standardized evaluation is essential for optimizing patient outcomes in mitral valve replacement.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
73
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
73
01:26Mitral Stenosis III: Medical Management
46
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
46
01:22Mitral Valve Prolapse II: Assessment and Management
72
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
72
01:22Mitral Stenosis I: Introduction
84
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
84
01:25Mitral Regurgitation III: Medical Management
54
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
54
01:20Mitral Regurgitation I: Introduction
82
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
82